back-button

    Dasatinib

    Information about Dasatinib

    Dasatinib uses

    Dasatinib is used in the treatment of chronic myeloid leukaemia
    It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

    How dasatinib works

    Dasatinib works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

    Common side effects of dasatinib

    Nausea, Vomiting, Abdominal pain, Rash, Headache, Edema, Reduced blood platelets, Musculoskeletal (bone, muscle or joint) pain, Breathing difficulty, Anemia, Fatigue, Infection, Fever, Bleeding

    Available Medicine for Dasatinib

    • ₹208283 to ₹211539
      Bms India Pvt Ltd
      2 variant(s)

    Expert advice for Dasatinib

    • Dasatinib is not recommended for use in patients <18 years of age.
    • Do not take medicines that neutralise stomach acids (antacids) within 2 hours before or 2 hours after taking dasatinib.
    • Tell your doctor if you are taking medicines to thin the blood or prevent clots, if you have or have had liver or heart problem or if you start having difficulty breathing, chest pain, or a cough while taking dasatinib. 
    • Exercise caution while taking dasatinib if you have been diagnosed with intolerance to lactose.
    • Do not drive or operate machinery while taking dasatinib as it may cause dizziness and blurring of vision.
    • Avoid if allergic to dasatinib or any of its ingredients.

    Frequently asked questions for Dasatinib

    Dasatinib

    Q. Is dasatinib FDA approved?
    Dasatinib is FDA approved for the use in the treatment of adults with chronic phase, accelerated phase, or myeloid or lymphoid blast phase chronic myeloid leukaemia.
    Q. Can I take ibuprofen with dasatinib?
    Using dasatinib together with ibuprofen may increase the risk of bleeding. The interaction may be more likely if you are an elderly or have kidney or liver disease. Please follow your doctor's advice regarding its use

    Content on this page was last updated on 30 May, 2017, by Dr. Varun Gupta (MD Pharmacology)